Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB

Transcription factor nuclear factor-κB (NF-κB) is constitutively activated in most pancreatic cancer tissues and cell lines but not in normal pancreas nor in immortalized/nontumorigenic human pancreatic ductal epithelial cells. Inhibition of constitutive NF-κB activation in pancreatic cancer cell lines suppresses tumorigenesis and tumor metastasis. Recently, we identified autocrine secretion of proinflammatory cytokine interleukin (IL)-1α as the mechanism of constitutive NF-κB activation in metastatic pancreatic cancer cell lines. However, the role of IL-1α in determining the metastatic potential of pancreatic tumor remains to be further investigated. In the current study, we stably expressed IL-1α in the nonmetastatic, IL-1α–negative MiaPaCa-2 cell lines. Our results showed that the secretion of IL-1α in MiaPaCa-2 cells constitutively activated NF-κB and increased the expression of NF-κB downstream genes involved in the different steps of the metastatic cascade, such as urokinase-type plasminogen activator, vascular endothelial growth factor, and IL-8. MiaPaCa-2/IL-1α cells showed an enhanced cell invasion in vitro compared with parental MiaPaCa-2 cells and induced liver metastasis in an orthotopic mouse model. The metastatic phenotype induced by IL-1α was inhibited by the expression of phosphorylation-defective IκB (IκB S32, 36A), which blocked NF-κB activation. Consistently, silencing the expression of IL-1α by short hairpin RNA in the highly metastatic L3.6pl pancreatic cancer cells completely suppressed their metastatic spread. In summary, these findings showed that IL-1α plays key roles in pancreatic cancer metastatic behavior through the constitutive activation of NF-κB. Our findings further support the possible link between inflammation and cancer and suggest that IL-1α may be a potential therapeutic target for treating pancreatic adenocarcinoma. (Mol Cancer Res 2009;7(5):624–33)

[1]  G. Tortora,et al.  LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis , 2008, Molecular Cancer Therapeutics.

[2]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[3]  S. Ethier,et al.  Activation of a Nuclear Factor κB/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer Cells , 2007, Molecular Cancer Research.

[4]  R. Wolff.  Chemotherapy for Pancreatic Cancer: From Metastatic Disease to Adjuvant Therapy , 2007, Cancer journal.

[5]  Peng Huang,et al.  Keratinocyte Growth Factor/Fibroblast Growth Factor-7-regulated Cell Migration and Invasion through Activation of NF-κB Transcription Factors* , 2007, Journal of Biological Chemistry.

[6]  D. Melisi,et al.  NF-κB as a target for cancer therapy , 2007 .

[7]  Y. Carmi,et al.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.

[8]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.

[9]  S. Argov,et al.  Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell‐associated IL‐1α , 2006, Journal of leukocyte biology.

[10]  Yoichi Matsuo,et al.  Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α6β1-integrin and urokinase plasminogen activator receptor expression , 2006, BMC Cell Biology.

[11]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[12]  Wei Zhang,et al.  Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  P. Chiao,et al.  Identification of an Autoregulatory Feedback Pathway Involving Interleukin-1α in Induction of Constitutive NF-κB Activation in Pancreatic Cancer Cells* , 2004, Journal of Biological Chemistry.

[14]  H. Sawai,et al.  Interleukin-1α Enhances Integrin α6β1 Expression and Metastatic Capability of Human Pancreatic Cancer , 2003, Oncology.

[15]  Douglas B. Evans,et al.  Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis , 2003, Oncogene.

[16]  H. Sawai,et al.  Enhancement of integrins by interleukin‐1α, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells , 2003, Journal of surgical oncology.

[17]  Douglas B. Evans,et al.  The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis , 2002, Oncogene.

[18]  Liang-sheng Lu,et al.  [Expression of fusion proteins in beta(2)GP I gene-transfected HEp-2 cells and its clinical application]. , 2002, Zhonghua yi xue za zhi.

[19]  H. Sawai,et al.  Alteration of Integrins by Interleukin-1&agr; in Human Pancreatic Cancer Cells , 2001 .

[20]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[21]  N. Perkins.  The Rel/NF-κB family: friend and foe , 2000 .

[22]  G. Sledge,et al.  Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. , 2000, Biochemical and biophysical research communications.

[23]  M. Plebani,et al.  Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. , 1999, Pancreas.

[24]  I. Fidler,et al.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. , 1999, Neoplasia.

[25]  E. Hovig,et al.  Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL. , 1998, Anticancer research.

[26]  S. Barsky,et al.  Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. , 1997, The American journal of pathology.

[27]  K. Ohama,et al.  Interleukin-1 as an autocrine stimulator in the growth of human ovarian cancer cells. , 1997, Hiroshima journal of medical sciences.

[28]  I. Verma,et al.  Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required , 1996, Molecular and cellular biology.

[29]  P. Musiani,et al.  IL‐1α gene‐transfected human melanoma cells increase tumor‐cell adhesion to endothelial cells and their retention in the lung of nude mice , 1996 .

[30]  N. Mori,et al.  Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. , 1996, Blood.

[31]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[32]  I. Verma,et al.  Autoregulation of I kappa B alpha activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Friess,et al.  Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival , 1993 .

[34]  H. Yokozaki,et al.  Interleukin 1α Acts as an Autocrine Growth Stimulator for Human Gastric Carcinoma Cells , 1993 .

[35]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[36]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[38]  Douglas B. Evans,et al.  Function of Nuclear Factor κB in Pancreatic Cancer Metastasis , 2003 .

[39]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[40]  D. V. Antwerp,et al.  Signal-Induced Degradation of IkBa: Association with NF-kB and the PEST Sequence in IkBa Are Not Required , 1996 .

[41]  M. Plebani,et al.  Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes , 1995 .

[42]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[43]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.